IMMX · Immix Biopharma, Inc. · Investor Relations
$9.82
-0.31 (-3.06%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company is unable to entirely fund these efforts with its current financial resources. If adequate funds are unavailable on a timely basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more of its research or development programs which may materially and adversely affect its business, financial condition and operations.”View the 10-Q filed Aug 7, 2026
Market Cap
$784.79M
Shares
71.54M
Volume · Oct 6
1.22M
Avg daily vol (3M)
1.71M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
No Investor Relations Content
No press releases or events have been collected for this stock yet.